MyoKardia, Inc.
(NASDAQ : MYOK)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -1.89%27.0014.1%$158.87m
HZNPHorizon Therapeutics Plc -0.95%80.435.6%$158.03m
ACRSAclaris Therapeutics, Inc. -4.57%17.975.3%$136.21m
CTLTCatalent, Inc. -0.13%119.672.1%$103.91m
BHCBausch Health Cos., Inc. -1.89%27.000.0%$102.08m
JAZZJazz Pharmaceuticals Plc 0.17%167.292.4%$86.77m
ACSTAcasti Pharma, Inc. 18.64%0.760.2%$71.66m
ISRIsoRay, Inc. 2.08%2.462.5%$65.10m
UTHRUnited Therapeutics Corp. -0.26%171.1714.1%$64.58m
AMRNAmarin Corp. Plc -1.43%6.201.5%$50.03m
PRGOPerrigo Co. Plc -0.44%43.286.8%$49.66m
GWPHGW Pharmaceuticals Plc 0.02%136.936.1%$48.40m
SAGESAGE Therapeutics, Inc. 1.85%91.217.6%$46.77m
ARGXargenx SE 6.40%305.360.0%$43.44m
ICLRICON plc 2.72%220.964.2%$41.59m

Company Profile

MyoKardia is a clinical-stage biopharmaceutical company that engages in discovering, developing, and commercializing targeted therapies for the treatment of rare cardiovascular diseases. The company's focus is on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It utilizes its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy and dilated cardiomyopathy. The company was founded in 2012 and is headquartered in Brisbane, California.